Skip to content

Clinical trials

Neuroblastoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Country / region: Netherlands Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20071
20121
20132
20141
20171
20191
20201
20212
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting4
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group5
Novartis Pharmaceuticals2
Princess Maxima Center for Pediatric Oncology2
AbbVie1
European Organisation for Research and Treatment of Cancer - EORTC1
Genzyme, a Sanofi Company1
German Society for Pediatric Oncology and Hematology GPOH gGmbH1
GlaxoSmithKline1
Hoffmann-La Roche1
Jakob Stenman1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma21
Neoplasms5
Astrocytoma3
Burkitt Lymphoma3
Leukemia, Myeloid, Acute3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Central Nervous System Neoplasms2
Dendritic Cell Sarcoma, Interdigitating2
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, Large-Cell, Anaplastic2

Trials

Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.